Clients


ManifestSeven Announces Expansion of Statewide Distribution Infrastructure

March 9th, 2021 - Ryan Allway

New vehicle fleet will increase fulfillment capacity and operating efficiencies of Highlanders, M7’s distribution division IRVINE, Calif., March 9, 2021 /PRNewswire/ — ManifestSeven Holdings Corporation (CSE: MSVN; OTCMKTS: MNFSF) (“M7” or the “Company“), California’s first integrated omnichannel platform for legal cannabis, today announced that it has more than tripled the size of its fleet of distribution vehicles, augmenting the Company’s logistics […]

Why DELIC’s Latest Acquisition is a Complete Game-Changer

March 8th, 2021 - Ryan Allway

The Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) team has been at the forefront of the cannabis industry for over a decade. After building High Times into the giant it is today, they founded DELIC as an umbrella platform to target the nascent psychedelics industry through a combination of media properties, high-profile events, wellness clinics […]

Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options

March 2nd, 2021 - Ryan Allway

Oakville, Ontario–(Newsfile Corp. – March 2, 2021) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, announced today that it has submitted an application to uplist the Company’s common shares on The Nasdaq Capital Market® (the “Nasdaq“) […]

Do International Cannabis Companies Deserve More Attention?

March 2nd, 2021 - Ryan Allway

Since the legal cannabis industry burst onto investors’ radar in 2014 the U.S. market and the Canadian markets have been the primary focus. The potential of the U.S. market in terms of sheer size, and the Canadian national recreational program and export opportunities have captured investor attention.  Interestingly, there are some U.S. and Canadian companies […]

There’s no Magic Answer to the Question, “Can I Patent Magic Mushrooms?”

February 24th, 2021 - Ryan Allway

“Patent pending” is a phrase you are likely familiar with. You have seen it stamped on the side of some doodad at the mall or heard it on the TV show that you are binge watching, and you think to yourself, “Wow, I wish I could invent something that everyone thinks is really cool”. Most […]

How California is Dominating the Cannabis Brand Landscape

February 24th, 2021 - Ryan Allway

California is well known for its brand dominance—from its Hollywood studios to its Napa Valley wines. As a tastemaker across industries, the state’s cannabis brands are well-positioned to follow in these footsteps and expand across the United States if and when the federal government legalizes cannabis nationwide. At the same time, manufactured products including gummies, […]

Building the ‘Omnichannel’ of Legal Cannabis in California

February 23rd, 2021 - Ryan Allway

  The cannabis industry is projected to be worth more than $73 billion by 2027, according to Grand View Research, which represents an 18.1% compound annual growth rate. Within this growing market, California generates nearly a third of all cannabis sales in the United States—or roughly the combined sales of Colorado, Washington, and Oregon. While […]

Cannabis 3.0: Investing in Profitability

February 23rd, 2021 - Ryan Allway

If you’ve been following the public cannabis markets for the past decade, you’ve seen a myriad of changes that can be bundled into a few major categories: The Canadian build up, the rise of the US MSO and the race to get profitable.  During the Canadian build up, call it Cannabis 1.0, it was all […]

Big Pharma Dives Into CBD: Who Could Be Next?

February 22nd, 2021 - Robin Lefferts

As many of you know, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) agreed in early February to acquire GW Pharmaceuticals plc (NASDAQ: GWPH) for a total price tag, including cash and shares, of $7.2 billion. GW Pharma is a pioneer in cannabinoid-based medicine, and its cannabidiol (CBD) formulation Epidiolex® is notably the first plant-derived cannabinoid medicine ever […]

Look for Bottom Line Performance in Cannabis Companies

February 22nd, 2021 - Robin Lefferts

  Some key features of Decibel Cannabis Company: Defining the upper echelon of premium cannabis brands with its own brand, Qwest Among the few profitable cannabis companies with growth ahead Short supplied with leading flower pricing – adding 4x flower production #1 and #3 in vapes and concentrates with 30+ product SKUs to come The […]

Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment of MS

February 18th, 2021 - Ryan Allway

Targeting innovative treatments for multiple sclerosis and other neuroinflammatory pathology Englewood Cliffs, NJ, Feb. 18, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders, announced today that […]

FinCanna Capital Announces Wholly Owned Green Compliance Inc., Delivers HIPAA Compliant Point-of-Sale Solutions for US Licensed Cannabis Dispensaries and Cultivators

February 17th, 2021 - Ryan Allway

VANCOUVER, BC / ACCESSWIRE / February 17, 2021 / FinCanna Capital Corp. (“FinCanna“) (CSE:CALI)(OTCQB:FNNZF), is pleased to provide a product and new feature update on its wholly owned royalty portfolio company Green Compliance Inc. (“Green Compliance“) and its ezGreen proprietary software that delivers HIPAA compliant point-of-sale (POS) solutions for licensed cannabis dispensaries and cultivators in the United States. […]

Revive Therapeutics Aims to Bring Psychedelics to Market

February 17th, 2021 - Ryan Allway

The psychedelic drug market is projected to grow at a 16.3% compound annual growth rate to reach nearly $7 billion by 2027, according to Data Bridge Market Research. While there are a growing number of publicly traded companies in the space, the best opportunities have the right combination of experience, intellectual property and clinical trials. […]

Decibel Cannabis Company Provides Update On Derivative Product Sales and Key Milestones

February 17th, 2021 - Ryan Allway

  CALGARY, AB, Feb. 17, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSX-V: DB) (OTCQB: DBCCF), a premium cannabis producer and retailer, is pleased to provide a business update regarding its recent launch of cannabis derivative products and other key milestones. “We’ve strongly positioned ourselves to succeed in the vape and concentrate market in Canada and are […]

Kaya Reaches Beyond Oregon

February 17th, 2021 - Ryan Allway

  In early 2014, in a small office in Hollywood, Florida, the management of what is today Kaya Holdings made the strategic decision to transition their existing small-cap publicly traded biofuels company away from alternative energy and exclusively toward the cultivation and retail of legal cannabis. This was no ordinary decision; Colorado and Washington had […]

ManifestSeven Launches New Local On-Demand Cannabis Delivery Operation in San Francisco Bay Area

February 16th, 2021 - Ryan Allway

Delivery hub in Brisbane opens Northern California market for Weden, M7’s direct-to-consumer division IRVINE, Calif., Feb. 16, 2021 /PRNewswire/ —  ManifestSeven Holdings Corporation (CSE: MSVN; OTCMKTS: MNFSF) (“M7” or the “Company“), California’s first integrated omnichannel platform for legal cannabis, today announced that its direct-to-consumer division, Weden, has commenced local on-demand delivery operations in Brisbane, California, strategically situated between San Francisco and Silicon Valley. (PRNewsfoto/ManifestSeven) M7’s new delivery hub in Brisbane complements […]

Psychedelics: Significant Investor Interest Despite the Pandemic

February 16th, 2021 - Ryan Allway

  The COVID-19 pandemic may be ravaging large swaths of the economy, but the stock market has consistently hit new record highs. After spending several years under-the-radar, the psychedelics industry is experiencing a renaissance driven by a combination of FDA-driven catalysts and soaring investor interest in a new class of potential blockbuster therapeutics.  Let’s take […]

Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor

February 11th, 2021 - Ryan Allway

La Jolla, California–(Newsfile Corp. – February 11, 2021) – Tryp Therapeutics (CSE: TRYP) (“Tryp” or the “Company”) a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today it has executed an advisory agreement with Dr. Joel Castellanos, a noted chronic pain physician at UC San Diego […]

HempFusion Launches Sleep and Stress Products With Twice the Amount of CBD

February 11th, 2021 - Ryan Allway

HempFusion 300 mg Sleep and Stress Support CBD Capsules (Photo: Business Wire) February 11, 2021 07:05 AM Eastern Standard Time DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce it has increased its product offering to 48 […]

ManifestSeven Doubles Down on Emerald Triangle with New Facility

February 9th, 2021 - Ryan Allway

California’s legal cannabis industry is on track to reach $7.2 billion in sales by 2024, according to Arcview Market Research and BDS Analytics, which represents a 19% compound annual growth rate. The Emerald Triangle region is widely considered to be the epicenter of that growth with its ideal microclimate and world-class operators. Let’s take a […]

Royalty Streaming: A Different Way to Get Exposure to the Cannabis Market

February 9th, 2021 - Ash Stringer

  When cannabis legalization started to gain momentum in 2012 with Washington and Colorado legalizing recreational marijuana, everyone knew it was going to be a big industry. For nearly a decade now, the investment community has ridden the volatility of the emerging market that generated $13.8 billion in sales in North America in 2019. Analysts […]

TRYP picks AstraZeneca’s Vaccine Development Partner

February 4th, 2021 - Ryan Allway

When AstraZeneca had to choose a development and manufacturing partner for their COVID vaccine, they chose AMRI. That’s why Tryp Therapeutics (CSE: TRYP) has chosen AMRI as their contract research and development partner. They’re the best in the business. AMRI… Who?  Albany Molecular Research Institute (AMRI) is a global contract research and development firm with facilities in North America, […]

Combining Traditional Therapies with Psychedelics: SiloPharma Targeting CNS and Neurological Disorders

February 4th, 2021 - Ryan Allway

“Psychedelics” is a buzz word on Wall Street, but much like legal cannabis or bitcoin and blockchain a decade ago, it remains greatly misunderstood as the market emerges. There was a time when psychedelics were only perceived as part of the illicit drug culture. That stigma is disappearing. Loaded with promise, the burgeoning market includes […]

Next Green Wave: A Hidden Gem in the Cannabis Industry

January 28th, 2021 - Ryan Allway

  The cannabis industry is projected to hit $30 billion in sales by 2023, according to Marijuana Business Daily, with California representing about 34% of U.S. sales. While there are many publicly traded companies in the space, there are only a handful that are growing and profitable with a truly experienced team both in the […]

3 Areas Psychedelics Could Address (and How to Invest in Them)

January 27th, 2021 - Ryan Allway

  Psychedelics have shown promise in the treatment of many treatment-resistant conditions, ranging from major depressive disorder to fibromyalgia. The therapeutic markets for these conditions could be worth billions of dollars per year, which has drawn the interest of both researchers and investors across North America. Let’s take a look at three areas where psychedelics […]

HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel

January 21st, 2021 - Ryan Allway

  DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has entered into a large-scale distribution agreement with Fullscript.com (“Fullscript”), a leading eCommerce platform that allows health professionals to dispense professional-grade natural health products. Fullscript […]

Psychedelic Wellness-Focused Company Delic Corp Announces U. S. OTCQB Listing on OTC Markets & DTC Eligibility

January 20th, 2021 - Ryan Allway

VANCOUVER, BC, Jan. 20, 2021 /CNW/ – Delic Holdings Corp. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce that its common shares are now trading on the OTCQB Venture Market under the symbol OTC: DELCF. The OTCQB Venture Market is the premiere marketplace for early stage and developing U.S. and […]

Delic Looks to Build a Sprawling ‘Psychedelic Ecosystem’

January 20th, 2021 - Ryan Allway

There have been a number of high profile initial public offerings in the psychedelic space, including COMPASS Pathways’ (NASDAQ: CMPS) $2 billion debut. While there are now more than 30 publicly traded companies in the space, there are thousands more private companies at various stages of funding and development.  Delic Corp. (CSE: DELC) (OTCQB: DELCF) […]

MagicMed: Bringing the Drug Candidate Library Model to Psychedelics

January 20th, 2021 - Ash Stringer

The psychedelics market is often described as “emerging”, “burgeoning”, and other similar words, and while certainly true to a large extent, investors shouldn’t think for a moment this is all new. It’s far from it. There are scores of clinical and preclinical data to leverage, most collected before the Controlled Substance Act was enacted in […]

HempFusion’s Wholly Owned Subsidiary Probulin Probiotics Launches Amazon Store and Expands Brick and Mortar Product Selection

January 19th, 2021 - Ryan Allway

DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its wholly owned subsidiary, Probulin Probiotics, LLC (“Probulin”), has increased its product selection in certain brick and mortar locations and expanded its distribution on Amazon through a […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading